ROL vs SRTS · P/E 41, rev $3.39B vs P/E 42, rev $41.8M
Rollins Inc (ROL) versus Sensus Healthcare Inc (SRTS) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Sensus Healthcare Inc (SRTS) is a medical devices company listed on US.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported SRTS revenue for 2024-12-31 was $41.8M. Net income was $6.6M. Revenue was up 71.3% from 2023-12-31 to 2024-12-31. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
Not investment advice. Open the ROL and SRTS stock pages for the full models.
Not investment advice.